标普和纳斯达克内在价值 联系我们

Exactus, Inc. EXDI OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
17/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Exactus, Inc. (EXDI) 是一家上市公司 属于 医疗保健 板块,经营于 制药 - 专科与仿制药 行业. 公司总部位于 Delray Beach, FL, 美国. 现任CEO为 Alvaro Daniel Alberttis.

EXDI 拥有 IPO日期为 2015-12-30, 在 Other OTC.

关于 Exactus, Inc.

Exactus, Inc. produces and supplies hemp-derived ingredients and feminized hemp genetics. It provides cannabidiol (CBD) feminized genetics, high cannabigerol (CBG) feminized genetics, hemp-derived specialty ingredients, and white-label products to the cosmetic, wellness, food, beverage, pharmaceutical, and pet industries. The company's specialty ingredients include CBD, CBG, CBN, and CBC isolates; CBD and CBG distillates; CBD water-soluble; CBD and CBG biomass; CBD AND CBG flowers; and CBD crude oil. It also provides a range of custom manufactured specialty cannabinoid products, such as skincare products, pain creams, tinctures, bath bombs, soft gels, balms, pet products, supplements, and other products. The company is based in Delray Beach, Florida. Exactus, Inc. is a subsidiary of Ceed2Med, LLC.

📍 80 NE 4th Avenue, Delray Beach, FL 📞 800 881 9352
公司详情
所属板块医疗保健
细分行业制药 - 专科与仿制药
国家美国
交易所Other OTC
货币USD
IPO日期2015-12-30
首席执行官Alvaro Daniel Alberttis
交易信息
当前价格$0.07
52周区间0.0505-0.073
Beta4.32
ETF
ADR
CUSIP30066P201
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言